BBI Solutions

Leading supplier of immunodiagnostic reagents BBI Solutions (BBI) has announced the launch of a full range of molecular tag gold conjugates.

BBI Solutions (BBI) today announced the launch of SCIPAC Clinical Specimen Panels. SCIPAC are quantitative panels of clinical specimen, collected from multiple donors of known genotype.

BBI Solutions (BBI), a world leader in purified human antigen manufacture has launched a fully validated recombinant Cystatin C to the IVD market.

Innovation, partnership, quality and results is the message from BBI Solutions

On Friday 19th May 2014, BBI Solutions employees swapped their lab coats for paint brushes, volunteering their time and skills in a one day make-over of Rumney RFC.

BBI Solutions (BBI), a world leader in immunoassay development and contract manufacturing has launched a synthetic Rubella IgM disease state serum to the world diagnostics market.

In a drive to support accurate results within the in-vitro diagnostics (IVD) industry, BBI Solutions are offering a 10% discount across their product range for all external quality assessment (EQA) schemes.